Ignite Creation Date:
2024-05-05 @ 11:49 AM
Last Modification Date:
2024-10-26 @ 9:14 AM
Study NCT ID:
NCT00147121
Status:
COMPLETED
Last Update Posted:
2016-09-22
First Post:
2005-09-05
Brief Title:
RituximabStandard CHOP vs RituximabBi-weekly CHOP for Untreated Stage IIIIV Low-grade B-cell Lymphoma JCOG0203
Sponsor:
Haruhiko Fukuda
Organization:
Japan Clinical Oncology Group
Organization Data
Organization:
Japan Clinical Oncology Group
Class:
OTHER
Study ID:
JCOG0203
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Haruhiko Fukuda
Lead Sponsor Class:
OTHER
Responsible Party:
Haruhiko Fukuda
Responsible Party Title:
JCOG Data Center
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Japan Clinical Oncology Group
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Ministry of Health Labour and Welfare Japan | OTHER_GOV |